|
rs7590387
|
|
|
0.010 |
GeneticVariation |
BEFREE |
When genotype distribution for RAMP1 rs7590387 was compared between healthy controls (n = 209) and MOH patients, carriers of rs7590387GG were found at lower risk of developing MOH (OR: 0.43, 95%CI: 0.22-0.85, P = 0.011).
|
25881990 |
2015 |
|
rs4680
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results indicate that genotyping for COMT rs4680 and SLC6A4 STin2 VNTR could be useful for the identification of MOH patients at higher risk of poor prognosis after drug withdrawal.
|
24684248 |
2014 |
|
rs1217691063
|
|
|
0.010 |
GeneticVariation |
BEFREE |
By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient dietary intake, and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) and dopamine D2 receptor (DRD2) C939T (rs6275) polymorphisms were selected as significant factors that contribute independently to the development from migraine to MOH (P < 0.05).
|
22290307 |
2013 |
|
rs1801133
|
|
|
0.010 |
GeneticVariation |
BEFREE |
By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient dietary intake, and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) and dopamine D2 receptor (DRD2) C939T (rs6275) polymorphisms were selected as significant factors that contribute independently to the development from migraine to MOH (P < 0.05).
|
22290307 |
2013 |
|
rs6275
|
|
|
0.010 |
GeneticVariation |
BEFREE |
By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient dietary intake, and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) and dopamine D2 receptor (DRD2) C939T (rs6275) polymorphisms were selected as significant factors that contribute independently to the development from migraine to MOH (P < 0.05).
|
22290307 |
2013 |
|
rs1042173
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Although a minor contribution of SLC6A4 variants in the genetic liability of MOH cannot be excluded, haplotype-based analysis of STin2 VNTR and rs1042173T>G polymorphisms allowed to identify a subgroup of MOH patients with a higher number of monthly headache and, possibly, with a more severe disease.
|
21585624 |
2012 |
|
rs6265
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism.
|
19517061 |
2009 |
|
rs759834365
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism.
|
19517061 |
2009 |
|
rs734312
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To test the influence of WFS1 polymorphisms on medication overuse headache (MOH), a chronic headache condition related to symptomatic drugs overuse, we analyzed 82 MOH patients for the WFS1 His611Arg polymorphism, and performed a comparison between clinical features of Arg/Arg (R/R) and non-R/R individuals.
|
17719176 |
2007 |